AS

About

Astex is a UK-based biotechnology company that discovers and develops novel small molecule therapeutics. Using its pioneering fragment-based drug discovery platform, Pyramid™, Astex has built a pipeline of molecularly-targeted oncology drugs, of which three are currently being tested in clinical trials with others in discovery and pre-clinical development. In addition to its proprietary research programs, Astex’s productivity in lead discovery has been endorsed through numerous partnerships with major pharmaceutical companies, including AstraZeneca, GlaxoSmithKline, Johnson & Johnson and Novartis.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 141 investors are based in Cambridge, Cambridgeshire, United Kingdom.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

in••••@astex-therapeutics.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Astex

Search Investors